Stanniocalcin 1 (STC1) in patients with refractory colorectal cancer (CRC) treated with regorafenib: An exploratory analysis of the CORRECT trial Meeting Abstract


Authors: Vienot, A.; Vernerey, D.; Bouard, A.; Klajer, E.; Asgarov, K.; Kim, S.; Tournigand, C.; Louvet, C.; André, T.; Rousseau, B.; Wespiser, M.; Wang, Y.; Schulz, A.; Dochy, E.; Borg, C.
Abstract Title: Stanniocalcin 1 (STC1) in patients with refractory colorectal cancer (CRC) treated with regorafenib: An exploratory analysis of the CORRECT trial
Meeting Title: ESMO 24th World Congress on Gastrointestinal Cancer 2022
Journal Title: Annals of Oncology
Volume: 33
Issue: Suppl. 4
Meeting Dates: 2022 Jun 29-Jul 2
Meeting Location: Barcelona, Spain
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2022-06-01
Start Page: S365
Language: English
ACCESSION: WOS:000823826500340
DOI: 10.1016/j.annonc.2022.04.419
PROVIDER: wos
Notes: Meeting Abstract: SO-20 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors